JP MORGAN/CALL/BECTON DICKINSON AND CO./250/0.1/17.01.25 Share Price

Warrant

DE000JL1KNS7

Real-time Bid/Ask 14:19:20 26/06/2024 BST
1.82 EUR / 1.92 EUR -3.11% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./250/0.1/17.01.25
Current month+24.52%
1 month+9.66%
Date Price Change
26/06/24 1.8 -6.74%
25/06/24 1.93 -6.31%
24/06/24 2.06 +0.49%
21/06/24 2.05 +11.41%
20/06/24 1.84 +1.10%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 11:15 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNS
ISINDE000JL1KNS7
Date issued 05/04/2023
Strike 250 $
Maturity 17/01/2025 (205 Days)
Parity 10 : 1
Emission price 3.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.69
Lowest since issue 1.36
Spread 0.1
Spread %5.21%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.9 USD
Average target price
279.2 USD
Spread / Average Target
+19.38%
Consensus